Literature DB >> 12657923

Toxicokinetics of nortriptyline and amitriptyline: two case reports.

E J F Franssen1, P W A Kunst, P M Bet, R J M Strack van Schijndel, A C van Loenen, A J Wilhelm.   

Abstract

Two cases are presented of intentional intoxications with the tricyclic antidepressants (TCAs) nortriptyline (NT) and amitriptyline (AT). The peak plasma concentrations were 2290 microg/L and 2900 microg/L, respectively. The active metabolites E-10-hydroxynortriptyline (EHNT) and Z-10-hydroxynortriptyline (ZHNT) profiles were quite different as monitored for 5 to 10 days after presumed drug intake. In conclusion, these cases illustrate that (1) metabolite formation and elimination after intake of an overdose dose of NT and AT are stereoselective, and (2) NT and EHNT toxicokinetics and toxicodynamics are quite different. It also shows that a patient with a severe TCA overdose can still survive if he or she receives appropriate and quick supportive care, even if the prognostic markers QRS time, coma grade, and serum TCA levels predict poor outcome.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12657923     DOI: 10.1097/00007691-200304000-00018

Source DB:  PubMed          Journal:  Ther Drug Monit        ISSN: 0163-4356            Impact factor:   3.681


  4 in total

1.  Prolonged toxicity after amitriptyline overdose in a patient deficient in CYP2D6 activity.

Authors:  Jennifer Cohen Smith; Steven C Curry
Journal:  J Med Toxicol       Date:  2011-09

Review 2.  Pharmacokinetic considerations in clinical toxicology: clinical applications.

Authors:  Darren M Roberts; Nick A Buckley
Journal:  Clin Pharmacokinet       Date:  2007       Impact factor: 6.447

3.  Amitriptyline-induced ventricular tachycardia: a case report.

Authors:  Khandker Mohammad Nurus Sabah; Abdul Wadud Chowdhury; Mohammad Shahidul Islam; Bishnu Pada Saha; Syed Rezwan Kabir; Shamima Kawser
Journal:  BMC Res Notes       Date:  2017-07-14

4.  A case report of a poor metabolizer of CYP2D6 presented with unusual responses to nortriptyline medication.

Authors:  Soo-Youn Lee; Chang-Seok Ki; Kyung Sue Hong; Jong Won Kim
Journal:  J Korean Med Sci       Date:  2004-10       Impact factor: 2.153

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.